Cargando…
enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9
While drug resistance mutations provide the gold standard proof for drug target engagement, target deconvolution of inhibitors identified from a phenotypic screen remains challenging. Genetic screening for functional in-frame drug resistance mutations by tiling CRISPR-Cas nucleases across protein co...
Autores principales: | Neggers, Jasper Edgar, Jacquemyn, Maarten, Dierckx, Tim, Kleinstiver, Benjamin Peter, Thibaut, Hendrik Jan, Daelemans, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791016/ https://www.ncbi.nlm.nih.gov/pubmed/33002419 http://dx.doi.org/10.1016/j.ymthe.2020.09.025 |
Ejemplares similares
-
Detecting Melanocortin 1 Receptor Gene’s SNPs by CRISPR/enAsCas12a
por: Yang, Wei, et al.
Publicado: (2023) -
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
por: Neggers, Jasper Edgar, et al.
Publicado: (2018) -
Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
por: Hart, Traver, et al.
Publicado: (2017) -
Anti-SpCas9 IgY
Polyclonal Antibodies Production for
CRISPR Research Use
por: León, Esteban, et al.
Publicado: (2023) -
In Planta Processing of the SpCas9–gRNA Complex
por: Mikami, Masafumi, et al.
Publicado: (2017)